Founded in 2004, Sphera Fund’s investment strategy aims to generate consistent returns that exceed the relevant indices on a risk-adjusted basis. Utilizing a long/short equity approach to investing, the fund focuses on stocks of large and mid-cap Israeli and Israeli-related companies mainly on the Tel Aviv 125 index and Nasdaq. Over the years, Sphera has built a unique team of investment professionals with long-standing experience and track record who seek to identify and access the most attractive opportunities in our investment universe.

Sphera Small-Cap is a long/short equity fund launched in 2011 and is focused on investments in equities of companies traded on the second and third-tier indices on the Tel Aviv Stock Exchange. These companies are often undervalued due to lack of research coverage and limited institutional followings. Sphera team’s experience and track record enable us to screen and access attractive investment opportunities in this particular market landscape.

Sphera Bond is a Long/Short Hedge Fund with the primary goal of consistently outperforming relevant Israeli bond indexes. With a focused strategy centered on fundamental analysis, our objective is to strategically identify and capitalize on market inefficiencies, providing investors with superior risk-adjusted returns. The fund specializes in investing in bonds of publicly traded companies, with an emphasis on repayment ability, credit quality, and capital structure. Investments are based on in-depth analysis, including continuous evaluation of cash flows, balance sheet strength, and duration versus risk. The fund also utilizes flexible tools such as short positions and may include selective equity holdings of up to 20% of the portfolio to take advantage of pricing inefficiencies and enhance return potential.

Sphera Tech Fund is a long/short equity strategy dedicated to investing in global and Israeli-related publicly-traded technology stocks. The fund aims to produce long term returns that exceed the relevant global equity indices on a risk-adjusted basis. The fund’s unique team profile combines our long standing investment experience with leading technology domain expertise across software, semiconductors, internet and more.Our team brings a wealth of insight and industry knowledge from their previous experience at companies such Meta, Qualcomm, Checkpoint and more.

With a focus on investments in the global pharmaceutical and biotechnology sectors, this long/short equity Fund was founded in 2007. Sphera Global Healthcare’s investments are based on comprehensive scientific research conducted by a team of scientists, doctors, and investment experts operating in Tel Aviv. The team of analysts is organized by therapeutic category, allowing deep insights and expertise in treatment modalities.

Founded in 2018, Sphera Biotech focuses on highly innovative small and mid-cap companies in the global biotechnology sector. Sphera Biotech’s investments are based on comprehensive scientific research conducted by teams of scientists, doctors, and investment experts operating in Tel Aviv. The team of analysts is organized by therapeutic category, allowing deep insights and expertise into treatment modalities. The investment team’s research process seeks to use this enhanced perspective to detect disruptive technologies at an early stage.